Skip to Content

Gentaur Nivolumab – Anti-PD-1 Antibody

https://research.gentaur.com/web/image/product.template/472746/image_1920?unique=02640f7
(0 review)
A research-grade biosimilar to nivolumab, targeting PD-1. Used in tumor immunology, TIL analysis, and immune modulation.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

Not Available For Sale

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

Our latest content

Check out what's new in our company !

Your Dynamic Snippet will be displayed here... This message is displayed because you did not provide both a filter and a template to use.